The annual Inc. 5000 ranking highlights independent businesses that demonstrate sustained revenue growth and operational scalability. For SNH, this inclusion serves as a benchmark for its strategy of integrating clinical rigor with pharmaceutical-grade standards. The company’s portfolio includes Troscriptions, which provides precision-dosed supplements, alongside support for the Health Optimization Medicine and Practice nonprofit.

Reflecting on the milestone, CEO Boomer Anderson credited the firm's small, dedicated team for the achievement. He emphasized that the repeat appearance on the list validates their internal model, noting that while he puts his name on the announcement, the growth is a direct product of the staff's daily focus on scientific accuracy and client care. The honorees will be celebrated at the upcoming Inc. 5000 Conference & Gala in Dallas this October.